State Boards of Pharmacy are lax in regulating compounding pharmacies, congressional report says

The state Boards of Pharmacy have been lax in regulating the practices of compounding pharmacies, like the New England Community Center, Framingham, Mass., implicated in the fungal meningitis outbreak. Instead, most of their enforcement actions have concentrated on compliance with traditional pharmacy licensing, controlled substances, and other requirements, according to a congressional report issued Oct. 29 by Rep. Edward J. Markey (D-Mass.).